Medications Used for the Treatment of Bladder Cancer and Associated ICD-10 Coding

Kristin A. Esposito, CPhT

Medications Used for the Treatment of Bladder Cancer and Associated ICD-10 Coding

Cancer Drug Coding, ICD Codes, Reimbursement

Clinical Services Manager, RJ Health Systems

This detailed article of codes related to bladder cancer is intended to assist practice managers and other healthcare providers and payers to ensure the proper use of coding and billing information associated with the treatment of patients with bladder cancer.

The following sections include:

Associated ICD-10-CM codes used for the classification of bladder cancer
Drugs that have been approved by the FDA for the treatment of bladder cancer
Drugs that are Compendia-listed for off-label use for bladder cancer based on clinical studies that suggest beneficial use in some cases. Please note: If a check mark appears in the FDA column, it will NOT appear in the Compendia off-label use column
Corresponding HCPCS/CPT^® codes and code descriptions
Possible CPT^® administration codes for the drugs

Associated ICD-10-CM Codes:

C67	Malignant neoplasm of bladder
	C67.0	Malignant neoplasm of trigone of bladder
	C67.1	Malignant neoplasm of dome of bladder
	C67.2	Malignant neoplasm of lateral wall of bladder
	C67.3	Malignant neoplasm of anterior wall of bladder
	C67.4	Malignant neoplasm of posterior wall of bladder
	C67.5	Malignant neoplasm of bladder neck
	C67.6	Malignant neoplasm of ureteric orifice
	C67.7	Malignant neoplasm of urachus
	C67.8	Malignant neoplasm of overlapping sites of bladder
	C67.9	Malignant neoplasm of bladder, unspecified
D09.0	Carcinoma in situ of bladder^a

Generic (brand) name

HCPCS/CPT^® code—code description

FDA approved for bladder cancer

Compendia off-label uses for bladder cancer

Possible CPT^® administration codes

atezolizumab (Tecentriq)	C9483 - Injection, atezolizumab, 10 mg	✔		96413, 96415
atezolizumab (Tecentriq)	J9999 - Not otherwise classified, antineoplastic drugs	✔		96413, 96415
avelumab (Bavencio)	C9491 - Injection, avelumab, 10 mg	✔		96413, 96415
avelumab (Bavencio)	J9999* - Not otherwise classified, antineoplastic drugs	✔		96413, 96415
bacillus Calmette-Guérin (Tice BCG)	90586^a - Bacillus Calmette-Guérin vaccine (BCG) for bladder cancer, live, for intravesical use	✔		51720
carboplatin (Paraplatin)	J9045 - Injection, carboplatin, 50 mg		✔	96409, 96413, 96415
cisplatin (Platinol AQ)	J9060 - Injection, cisplatin, powder or solution, per 10 mg	✔		96409, 96413, 96415
docetaxel (Taxotere)	J9171 - Injection, docetaxel, 1 mg		✔	96413
doxorubicin HCl (Adriamycin)	J9000 - Injection, doxorubicin hydrochloride, 10 mg	✔		96409
epirubicin (Ellence)	J9178 - Injection, epirubicin hydrochloride, 2 mg		✔	96409, 96413
fluorouracil (Adrucil)	J9190 - Injection, fluorouracil, 500 mg		✔	96409
gemcitabine (Gemzar)	J9201 - Injection, gemcitabine hydrochloride, 200 mg		✔	96413
ifosfamide (Ifex)	J9208 - Injection, ifosfamide, 1 gram		✔	96413, 96415
interferon alfa-2b (Intron-A)	J9214 - Injection, interferon, alfa-2b, recombinant, 1 million units		✔	96372, 96401
methotrexate	J9250 - Methotrexate sodium, 5 mg		✔	96372, 96374, 96401, 96409, 96450
methotrexate	J9260 - Methotrexate sodium, 50 mg		✔	96372, 96374, 96401, 96409, 96450
mitomycin (Mutamycin)	J9280 - Mitomycin, 5 mg		✔	96409
mitoxantrone (Novantrone)	J9293 - Injection, mitoxantrone hydrochloride, per 5 mg		✔	96409, 96413
nivolumab (Opdivo)	J9299 - Injection, nivolumab, 1 mg	✔		96413, 96415
paclitaxel (Taxol)	J9265 - Injection, paclitaxel, 30 mg		✔	96413, 96415
pembrolizumab (Keytruda)	J9271 - Injection, pembrolizumab, 1 mg	✔		96413
pemetrexed (Alimta)	J9305 - Injection, pemetrexed, 10 mg		✔	96409
porfimer sodium (Photofrin)	J9600 - Injection, porfimer sodium, 75 mg		✔	96409
tamoxifen (Nolvadex)	J8999* - Prescription drug, oral, chemotherapeutic, not otherwise specified		✔	N/A
tamoxifen (Nolvadex)	S0187 - Tamoxifen citrate, oral, 10 mg		✔	N/A
thiotepa	J9340 - Injection, thiotepa, 15 mg	✔		51720, 96409
topotecan (Hycamtin)	J9351 - Injection, topotecan, 0.1 mg		✔	96413
vinBLAStine (Velban)	J9360 - Injection, vinblastine sulfate, 1 mg		✔	96409
vinCRIStine (Vincasar PFS)	J9370 - Vincristine sulfate, 1 mg		✔	96409
valrubicin (Valstar)	J9357 - Injection, valrubicin, intravesical, 200 mg	✔		51720
^aThis drug is specific (and is the only drug specific) for carcinoma in situ of bladder.
When billing a nonclassified medication using a CMS 1500 claim form you must include both the HCPCS code (eg, J9999 Tecentriq) in Item 24D and the drug name, strength, and NDC (National Drug Code) in Item 19 or 24A shaded area to ensure appropriate reimbursement. Please note:* check with your payer regarding correct placement of Medication Information in Item 19 or 24A shaded area.
References • HCPCS Level II Expert 2017 • Current Procedural Terminology (CPT^®) 2017 • CPT^® Copyright © 2017 American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association • ICD-10-CM Professionals Edition Volume 1 & 2 2017 • FDA-approved indication (product prescribing information) • Compendia references available upon request • www.ReimbursementCodes.com powered by RJ Health Systems International, LLC, Rocky Hill, CT • CMS (Centers for Medicare & Medicaid Services)
HCPCS indicates Healthcare Common Procedure Coding System.

Medications Used for the Treatment of Bladder Cancer and Associated ICD-10 Coding

Associated ICD-10-CM Codes:

Top Trending Articles

CONNECT

Subscribe to
Oncology Practice Management

I'd like to recieve:

Medications Used for the Treatment of Bladder Cancer and Associated ICD-10 Coding

Associated ICD-10-CM Codes:

Related Articles

Top Trending Articles

CONNECT

Subscribe to Oncology Practice Management

I'd like to recieve:

Subscribe to
Oncology Practice Management